Editas Medicine (EDIT) Stock Chart & Stock Price History $3.08 +0.22 (+7.69%) Closing price 07/9/2025 04:00 PM EasternExtended Trading$3.12 +0.04 (+1.30%) As of 04:15 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Editas Medicine Stock Price Performance The Editas Medicine (EDIT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 39.37%, with a year-to-date return of 142.52%. In the past month, the stock has increased 46.67%, reflecting recent market activity. As of the latest close, Editas Medicine traded at $3.08 with a market cap of $257.84 million and volume of 5.59 million shares. Five years ago, the stock traded at $32.88, representing a 90.63% decrease over that period. At the time, it had a market cap of $1.90 billion and a volume of 769,600 shares. Receive EDIT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+19.15%1 Month Performance+46.67%3 Month Performance+177.48%Year-To-Date Performance+142.52%1 Year Performance-39.37%5 Year Performance-90.63% EDIT Stock Chart for Thursday, July, 10, 2025 EDIT Chart by TradingView Editas Medicine Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/09/2025$2.86$3.08+7.69%$3.24$2.925.59 million shs$257.84 million07/08/2025$2.54$2.86+12.60%$3.07$2.545.70 million shs$239.41 million07/07/2025$2.59$2.54-1.74%$2.63$2.482.14 million shs$212.62 million07/04/2025$2.59$2.59$2.75$2.511.91 million shs$216.39 million07/03/2025$2.56$2.59+0.98%$2.75$2.511.91 million shs$216.39 million07/02/2025$2.25$2.56+13.78%$2.88$2.239.52 million shs$214.30 million07/01/2025$2.20$2.25+2.27%$2.31$2.111.75 million shs$188.35 million06/30/2025$2.28$2.20-3.51%$2.37$2.192.24 million shs$184.17 million06/27/2025$2.12$2.28+7.55%$2.33$2.135.46 million shs$190.86 million06/26/2025$2.19$2.12-3.20%$2.22$2.082.31 million shs$177.47 million Get the Latest News and Ratings for EDIT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. 06/25/2025$2.25$2.19-2.67%$2.29$2.142.26 million shs$183.33 million06/24/2025$2.10$2.25+7.14%$2.31$2.153.02 million shs$188.35 million06/23/2025$2.22$2.10-5.41%$2.24$2.021.78 million shs$175.79 million06/20/2025$2.35$2.22-5.53%$2.39$2.153.06 million shs$185.84 million06/19/2025$2.35$2.35$2.38$2.053.58 million shs$196.72 million06/18/2025$2.14$2.35+9.81%$2.38$2.053.58 million shs$196.72 million06/17/2025$2.16$2.14-0.93%$2.55$2.105.46 million shs$179.15 million06/16/2025$1.97$2.16+9.64%$2.20$1.942.81 million shs$180.82 million06/13/2025$2.18$1.97-9.63%$2.12$1.943.05 million shs$164.92 million06/12/2025$2.03$2.18+7.39%$2.30$1.973.19 million shs$182.49 million06/11/2025$2.10$2.03-3.33%$2.19$2.012.01 million shs$169.94 million06/10/2025$1.93$2.10+8.81%$2.23$1.922.88 million shs$175.80 million06/09/2025$1.91$1.93+1.05%$2.02$1.851.22 million shs$161.57 million Related Companies Beam Therapeutics Stock Chart CRISPR Therapeutics Stock Chart Intellia Therapeutics Stock Chart Cronos Group Stock Chart Immunome Stock Chart Xeris Biopharma Stock Chart ArriVent BioPharma Stock Chart Pharming Group Stock Chart Vir Biotechnology Stock Chart Replimune Group Stock Chart Receive EDIT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EDIT) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting—or plan to collect—Social Security, this could be a game-changer. A new initiative tie...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Editas Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Editas Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
